Viral antigen prepared by heat inactivation of vaccinia virus stimulated production of interferon in association with transformation of sensitized human lymphocytes in vitro. Involvement of a macrophage-lymphocyte interaction in production of interferon stimulated by viral antigen was found in which macrophages greatly augmented the amount of interferon produced by lymphocytes. Reimmunization with live vaccinia virus resulted in a selective increase in the ability of lymphocytes to produce interferon in the presence of viral antigen 4-7 weeks later without a corresponding increase in the degree of already significant lymphocyte transformation. There was no correlation between the extent of lymphocyte transformation and the amount of interferon produced. The augmented interferon response after reimmunization described in this study may be a significant component of the protective effect of immunization with vaccinia against disease occurring after exposure to smallpox.
Epstein et al. demonstrated that a macrophage-lymphocyte interaction is involved in the mitogen-(1, 2) and antigen- (3, 4) stimulated production of interferon in cultures derived from human peripheral blood. Such interferon production occurred in association with the transformation of small lymphocytes to large blast-like cells observed in response to the nonspecific mitogen, phytohemagglutinin (PHA) , and in the more specific immune reaction when sensitized lymphocytes transform in response to purified protein derivative (PPD). In both situations, lymphocytes were identified as the most likely cells responsible for the production of interferon, but the presence of macrophages greatly augmented the amount of interferon produced.
Numerous authors have reported the transformation of sensitized human lymphocytes in response to smallpox vaccine (5-1 1). With one exception, the smallpox vaccine used contained live vaccinia virus, and the possibility that replication of vaccinia in leukocytes contributed to the response could not be ruled out. Many other studies have demonstrated interferon production in cultured leukocytes stimulated by vaccinia virus (12, 13) as well as by other viruses (14, 15) . Furthermore, cultures of leukocytes from animals immune to a given virus produced greater amounts of interferon when exposed to that virus than similar cultures from nonimmune animals (15) . The present studies were therefore undertaken to answer the following questions:
(a) Can human lymphocytes transform and produce interferon on an immune specific basis in response to a nonreplicating vaccinia virus antigen?
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(b) Is involvement of a macrophage-lymphocyte interaction necessary in the production of interferon as has been observed with mitogen-and nonviral-antigen-stimulated interferon production?
(c) Would reimmunization of donors with live vaccinia virus affect the degree of lymphocyte transformation and/or interferon production that occurred in vitro in response to the viral antigen?
It was hoped that such experiments would lead to greater understanding of both the cellular immune response to virus infections, and the mechanisms involved in viral immunizations.
MATERIALS AND METHODS
Blood Donors. Healthy individuals whose leukocyte and differential counts were within normal limits, and who had no history of recent viral illness, served as blood donors. Eight of them were adults who had been immunized with vaccinia virus 2-30 years before the onset of the study and five of them were children who served as nonvaccinated negative controls. Vaccination had been contraindicated in the children because of a personal or sibling's history of asthma and/or atopic dermatitis. Blood samples from the adults were drawn before and 4-22 weeks after reimmunization. At the time of harvest, cultures were passed through a 10-place filter holder (Hoefer Scientific Instruments) with each filter port containing a Whatman Glass Filter-Paper disc (W. and R. Balston, Ltd.) supported by a disc of Whatman no. 1 filter paper, and the supernatant culture fluid was collected in sterile vials for interferon assay. For determination of the degree of incorporation of [3H]thymidine into DNA as a measure of lymphocyte transformation, the cell pellets were then washed twice with cold phosphate buffered saline (pH 7.4), cold 5% trichloroacetic acid, and cold absolute methanol. The glass filter papers were then transferred and kept in scintillation vials containing 1 ml Nuclear-Chicago Solubilizer for several hours. 10 ml of scintillation fluid were then added to each vial, and the samples were counted as described (1).
Interferon Assay. A plaque reduction assay with fibroblasts from human neonatal foreskin and bovine vesicular stomatitis virus was used for interferon assay (1, 16) . Interferon titer was defined as that dilution of sample which, in a 4-ml volume, resulted in 50% reduction of viral plaques. In Fig. 1 . Before reimmunization, all donors manifested significant lymphocyte transformation in response to VH, with a 13-to 137-fold increase over that observed in cultures prepared with no stimulant present. After reimmunization with live vaccinia virus, significant amounts of transformed lymphocytes were again observed, but neither consistently higher nor lower than the amounts observed before reimmunization. For example, at 4 weeks three donors showed higher and three showed lower amounts of transformation than those observed before reimmunization. The degree of lympho- cyte transformation both before and after reimmnunization was always significantly higher than that observed in cultures prepared with no stimulant. Similarly, the response seen in YH-treated combined cultures was at all times significantly higher (2-to 26-fold) than in combined cultures treated with YR control. No interferon was noted in YH control-treated cultures.
Relationship between VH-stimulated interferon production and lymphocyte transformation Two representative time-course studies performed 4 weeks after reimmunization are presented in Fig. 3 time between these two parameters of the in vitro cellular response to an antigen was reported previously with PPD in combined cultures from sensitized individuals (3, 4) . In that situation also, maximum interferon production followed peak incorporation of [3H]thymidine. No correlation between the extent of erythema, induration, or vesicle formation at the site of vaccination was found with either the extent of maximum lymphocyte transformation or with maximum interferon production. As was demonstrated with PHA-and PPD-stimulated interferon (1-4) , VH-stimulated interferon was destroyed by the action of trypsin. Its activity was unaffected by ultracentrifugation at 100,000 X g, but was depressed by 50% by heating at 560 for 1 hr. Considerable activity was lost after exposure of the interferon to pH 2 for 6 hr. Species specificity was demonstrated by the inability of the VH-stimulated interferon to confer protection on feline fibroblasts, when challenged with vesicular stomatitis virus. However, barely detectable levels of protection were afforded mouse L cells. Exposure of the confluent monolayers of neonatal foreskin fibroblasts to the culture supernatants that contained interferon for only 2 hr instead of the customary 18-24 hr was not sufficient for the interferon to exert its protective effect.
DISCUSSION
The present studies demonstrate that it is possible to prepare a viral antigen from vaccinia virus that will result in transformation of sensitized lymphocytes and in an associated production of interferon in vitro. Although the precise antigenic composition of the VH used in these studies is not known, three lines of evidence support the conclusion that the events observed in vitro were a direct consequence of a specific immunologic response to VH. First, no significant lymphocyte transformation or interferon production was could be attributed to their reaction to HeLa-cell antigens. Third, a definite increase in in vitro interferon production was noted in response to reimmunization with live vaccinia virus. 4-7 weeks after reimmunization, 7 of 8 donors showed a significant increase in the amount of interferon stimulated in vitro by VH. These studies also demonstrate the involvement of a macrophage-lymphocyte interaction in in vitro production of viral antigen-stimulated interferon that is similar to that observed with PHA-or PPD-stimulated interferon (1-4) . The presence of macrophages in VH-stimulated, combined cultures greatly augmented the degree of transformation and interferon production over that observed with just lymphocytes alone. As had been observed with PHA and PPD (1) (2) (3) (4) , no interferon production was ever noted in VH-stimulated cultures containing macrophages alone. This, plus the fact that repeated freeze-thawing of lymphocytes before combination with macrophages and PHA or VH completely prevents lymphocyte transformation and subsequent interferon production, strongly suggests that lymphocytes are the cell-types responsible for in vitro production of interferon in response to a viral antigen.
From the present data, it is not possible to determine the exact mechanism of the increased interferon response observed after reimmunization. Yet, it seems reasonable to assume that it occurred either because of an increase in the number or productive capacity of the lymphocytes that produce interferon. Furthermore, they might be a separate population from, or a subpopulation of, these lymphocytes that respond to viral antigen with lymphocyte transformation and proliferation. This hypothesis is supported by the observations, in the present study, that reimmunization with live virus did not result in an increase in the already significant levels of lymphocyte transformation stimulated by viral antigen, observed before reimmunization, but did result in an increase in the ability of sensitized lymphocytes to respond to viral antigen with the increased production of interferon.
The latter observation may well provide a new explanation for the protection against smallpox that is afforded by revaccination. The importance of cell-mediated immunity in defense against pox viruses has been suggested in man (17, 18) and animals (19) (20) (21) (22) . Interferon seems to function as a mediator of cellular immunity (23, 3, 4) and has been detected at the dermal site of vaccination (24, 25) . Also, enhanced local interferon production by immunized mice has been observed after intracranial challenge with vaccinia (26) . That such local interferon may play a very important role in recovery or resistance to reinfection has been documented by studies of Varicella zoster (another enveloped DNA virus affecting the skin) in patients with impaired cell-mediated immunity (27) . It was shown, in such patients, that a delay in appearance of interferon at the local site was associated with severe progressive infections and that the appearance of high local titers of interferon signaled the onset of recovery.
Thus, the phenomenon reported herein, that reimmunization with live virus results in increased interferon production by sensitized lymphocytes, may be of critical importance in local areas with high concentrations of viral antigens, and thereby contribute to the protective effect of smallpox vaccination. Local interferon production as a component of cellular immunity may also function together with humoral immunity in recovery from viral disease.
